Cargando…
Oncological Outcomes in Rats Given Nephrocarcinogenic Exposure to Dietary Ochratoxin A, Followed by the Tumour Promoter Sodium Barbital for Life: A Pilot Study
The potent experimental renal carcinogenesis of ochratoxin A (OTA) in male rats makes the dietary contaminant a potential factor in human oncology. We explored whether the tumour promoter sodium barbitate could shorten the otherwise long latency between exposure to toxin and tumourigenesis. Young ra...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153215/ https://www.ncbi.nlm.nih.gov/pubmed/22069599 http://dx.doi.org/10.3390/toxins2040552 |
_version_ | 1782209865653944320 |
---|---|
author | Mantle, Peter G. Dobrota, Miloslav Gillett, Cheryl E. Odell, Edward W. Pinder, Sarah E. |
author_facet | Mantle, Peter G. Dobrota, Miloslav Gillett, Cheryl E. Odell, Edward W. Pinder, Sarah E. |
author_sort | Mantle, Peter G. |
collection | PubMed |
description | The potent experimental renal carcinogenesis of ochratoxin A (OTA) in male rats makes the dietary contaminant a potential factor in human oncology. We explored whether the tumour promoter sodium barbitate could shorten the otherwise long latency between exposure to toxin and tumourigenesis. Young rats, of a hybrid in which mononuclear leukaemia was rare, were given feed contaminated (5 ppm) with OTA for 36 weeks to initiate renal tumourigenesis. Some individuals were thereafter given sodium barbitate (500 ppm in drinking water) for life. Pathological outcomes were studied at or near the end of natural life. Renal tumours in males given barbitate became evident after latency of one year, but only slightly before those without barbitate. In contrast, female mammary tumourigenesis was advanced by at least 6 months synchronously in all rats given the OTA-barbitate regimen compared to tumourigenesis in controls. Diagnosis of malignant mammary angiosarcoma in a female given the OTA-barbitate regimen is a new finding in the rat. The long latency of OTA-induced renal tumourigenesis was not notably susceptible to accelerated promotion by barbitate, contrasting with an apparently marked effect of barbitate on development of mammary tumours. |
format | Online Article Text |
id | pubmed-3153215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Molecular Diversity Preservation International |
record_format | MEDLINE/PubMed |
spelling | pubmed-31532152011-11-08 Oncological Outcomes in Rats Given Nephrocarcinogenic Exposure to Dietary Ochratoxin A, Followed by the Tumour Promoter Sodium Barbital for Life: A Pilot Study Mantle, Peter G. Dobrota, Miloslav Gillett, Cheryl E. Odell, Edward W. Pinder, Sarah E. Toxins (Basel) Article The potent experimental renal carcinogenesis of ochratoxin A (OTA) in male rats makes the dietary contaminant a potential factor in human oncology. We explored whether the tumour promoter sodium barbitate could shorten the otherwise long latency between exposure to toxin and tumourigenesis. Young rats, of a hybrid in which mononuclear leukaemia was rare, were given feed contaminated (5 ppm) with OTA for 36 weeks to initiate renal tumourigenesis. Some individuals were thereafter given sodium barbitate (500 ppm in drinking water) for life. Pathological outcomes were studied at or near the end of natural life. Renal tumours in males given barbitate became evident after latency of one year, but only slightly before those without barbitate. In contrast, female mammary tumourigenesis was advanced by at least 6 months synchronously in all rats given the OTA-barbitate regimen compared to tumourigenesis in controls. Diagnosis of malignant mammary angiosarcoma in a female given the OTA-barbitate regimen is a new finding in the rat. The long latency of OTA-induced renal tumourigenesis was not notably susceptible to accelerated promotion by barbitate, contrasting with an apparently marked effect of barbitate on development of mammary tumours. Molecular Diversity Preservation International 2010-03-31 /pmc/articles/PMC3153215/ /pubmed/22069599 http://dx.doi.org/10.3390/toxins2040552 Text en © 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Mantle, Peter G. Dobrota, Miloslav Gillett, Cheryl E. Odell, Edward W. Pinder, Sarah E. Oncological Outcomes in Rats Given Nephrocarcinogenic Exposure to Dietary Ochratoxin A, Followed by the Tumour Promoter Sodium Barbital for Life: A Pilot Study |
title | Oncological Outcomes in Rats Given Nephrocarcinogenic Exposure to Dietary Ochratoxin A, Followed by the Tumour Promoter Sodium Barbital for Life: A Pilot Study |
title_full | Oncological Outcomes in Rats Given Nephrocarcinogenic Exposure to Dietary Ochratoxin A, Followed by the Tumour Promoter Sodium Barbital for Life: A Pilot Study |
title_fullStr | Oncological Outcomes in Rats Given Nephrocarcinogenic Exposure to Dietary Ochratoxin A, Followed by the Tumour Promoter Sodium Barbital for Life: A Pilot Study |
title_full_unstemmed | Oncological Outcomes in Rats Given Nephrocarcinogenic Exposure to Dietary Ochratoxin A, Followed by the Tumour Promoter Sodium Barbital for Life: A Pilot Study |
title_short | Oncological Outcomes in Rats Given Nephrocarcinogenic Exposure to Dietary Ochratoxin A, Followed by the Tumour Promoter Sodium Barbital for Life: A Pilot Study |
title_sort | oncological outcomes in rats given nephrocarcinogenic exposure to dietary ochratoxin a, followed by the tumour promoter sodium barbital for life: a pilot study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153215/ https://www.ncbi.nlm.nih.gov/pubmed/22069599 http://dx.doi.org/10.3390/toxins2040552 |
work_keys_str_mv | AT mantlepeterg oncologicaloutcomesinratsgivennephrocarcinogenicexposuretodietaryochratoxinafollowedbythetumourpromotersodiumbarbitalforlifeapilotstudy AT dobrotamiloslav oncologicaloutcomesinratsgivennephrocarcinogenicexposuretodietaryochratoxinafollowedbythetumourpromotersodiumbarbitalforlifeapilotstudy AT gillettcheryle oncologicaloutcomesinratsgivennephrocarcinogenicexposuretodietaryochratoxinafollowedbythetumourpromotersodiumbarbitalforlifeapilotstudy AT odelledwardw oncologicaloutcomesinratsgivennephrocarcinogenicexposuretodietaryochratoxinafollowedbythetumourpromotersodiumbarbitalforlifeapilotstudy AT pindersarahe oncologicaloutcomesinratsgivennephrocarcinogenicexposuretodietaryochratoxinafollowedbythetumourpromotersodiumbarbitalforlifeapilotstudy |